Blog

Key Learnings The landscape of drug development is dynamic, and innovative drug modalities like exosomes can present unique challenges that require both expertise and adaptability in bioanalytical assay development. In this blog, we showcase how our team tackled these challenges with Drug B, an exosome-based therapy targeting T cells and natural killer cells for lymphoma…